Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Kezar Life Sciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- +5 vs. Q2 2022
- Shares held
- 57.5M
- +2.64M (+4.8%) vs. Q2 2022
- Total value
- $495.5M
- +$41.5M (+9.1%) vs. Q2 2022
- New holders
- 25
- 60 more added
- Sold out
- 20
- 31 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Granahan Investment Management Inc | 447,418 | $3.85M | 0.13% | +171,254+62.0% | Added |
| Two Sigma Advisers, LP | 472,700 | $4.07M | 0.01% | −182,100−27.8% | Reduced |
| Ghost Tree Capital, LLC | 525,000 | $4.52M | 1.85% | +75,000+16.7% | Added |
| Woodline Partners LP | 580,177 | $5.00M | 0.07% | +580,177 | New |
| Novo Holdings A/S | 598,377 | $5.15M | 0.25% | +598,377 | New |
| Palo Alto Investors LP | 656,200 | $5.65M | 0.45% | 00.0% | Unchanged |
| Marshall Wace, LLP | 658,440 | $5.67M | 0.01% | −1,250,075−65.5% | Reduced |
| Dimensional Fund Advisors LP | 707,766 | $6.09M | 0.00% | +323,726+84.3% | Added |
| Tri Locum Partners LP | 709,733 | $6.11M | 1.74% | +205,391+40.7% | Added |
| Ikarian Capital, LLC | 728,586 | $6.27M | 3.13% | −679,530−48.3% | Reduced |
| Qiming U.S. Ventures Management, LLC | 828,711 | $7.13M | 10.36% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 940,899 | $8.10M | 0.00% | +164,785+21.2% | Added |
| Logos Global Management LP | 950,000 | $8.18M | 1.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 953,592 | $8.21M | 0.00% | +271,020+39.7% | Added |
| Northern Trust Corp | 976,531 | $8.41M | 0.00% | +50,012+5.4% | Added |
| JPMorgan Chase & Co | 1,057,748 | $9.11M | 0.00% | −43,788−4.0% | Reduced |
| Sphera Funds Management Ltd. | 1,245,806 | $10.7M | 1.90% | +946,152+315.7% | Added |
| Prosight Management, LP | 1,327,899 | $11.4M | 6.28% | +65,208+5.2% | Added |
| Franklin Resources Inc | 1,365,323 | $11.8M | 0.01% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 1,377,297 | $11.9M | 0.00% | +800,540+138.8% | Added |
| Hood River Capital Management LLC | 1,382,937 | $11.9M | 0.46% | +21,817+1.6% | Added |
| HealthCor Management, L.P. | 1,607,650 | $13.8M | 1.73% | +397,770+32.9% | Added |
| CHI Advisors LLC | 1,762,793 | $15.2M | 4.08% | −78,000−4.2% | Reduced |
| OrbiMed Advisors LLC | 1,771,700 | $15.3M | 0.30% | +351,800+24.8% | Added |
| Victory Capital Management Inc | 2,359,492 | $20.3M | 0.02% | −410,606−14.8% | Reduced |
| Millennium Management LLC | 2,962,268 | $25.5M | 0.03% | +213,322+7.8% | Added |
| Vanguard Group Inc | 2,993,207 | $25.8M | 0.00% | +556,020+22.8% | Added |
| Bellevue Group AG | 3,031,000 | $26.1M | 0.37% | −4,000−0.1% | Reduced |
| Suvretta Capital Management, LLC | 3,275,520 | $28.2M | 1.19% | −1,136,780−25.8% | Reduced |
| State Street Corp | 3,537,701 | $30.5M | 0.00% | +2,802,611+381.3% | Added |
| BlackRock Inc. | 4,104,929 | $35.3M | 0.00% | +525,139+14.7% | Added |
| Avidity Partners Management LP | 5,414,400 | $46.6M | 1.01% | +1,364,400+33.7% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,608,400−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,419,000−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,200,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −252,000−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −94,062−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −84,584−100.0% | Sold out |
| HAP Trading, LLC | 0 | $0 | 0.00% | −79,215−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −39,005−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −38,490−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −32,449−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −27,200−100.0% | Sold out |
| Ellsworth Advisors, LLC | 0 | $0 | 0.00% | −25,840−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −24,022−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −17,300−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −16,611−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,009−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −51−100.0% | Sold out |